Mobile

A Phase II, Double-blind, Randomized Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination wi...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003443-31

A Phase II, Double-blind, Randomized Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination with FOLFOX in the Second-line Treatment of Patients with Metastatic Colorectal Cancer

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Determine the efficacy of AZD2171 in combination with FOLFOX compared to efficacy of bevacizumab in combination with FOLFOX by assessment of PFS

Critère d'inclusion

  • Metastatic colorectal cancer

Liens